Aquestive Therapeutics Stock (NASDAQ: AQST)

Aquestive Therapeutics

AQUESTIVE THERAPEUTICS INC

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

Auto,Epinephrine,Injector.,Patient,Doing,Leg,Injection

Analyst Color

Biotech

Equities

News

Health Care

Price Target

Initiation

Analyst Ratings

Trading Ideas

General

AQST

Cantor initiates coverage on Aquestive Therapeutics, highlighting Anaphylm&#39;s potential to disrupt the epinephrine auto-injector market with 200% upside.

Developer Of EpiPen Alternative Aquestive Stock Undervalued Despite Strong Clinical Data, Analyst Sees Huge Upside

Genetic,Research,And,Biotech,Science,Concept.,Human,Biology,And,Pharmaceutical

Movers

INCY

Aquestive Therapeutics hosted a virtual investor day, announcing advancements in Anaphylm and AQST-108. The company aims for FDA meetings in late 2024, targeting a 2025 NDA submission, while HC Wainwright raises its price target amid promising developments.

Optimism Around Aquestive As it Moves Forward With Severe Allergy, Baldness Candidate

Allergy,Food,Concept.,Food,On,Wooden,Table

Oral Allergy Medication For Emergencies - Aquestive Therapeutics&#39; Investigational Therapy Works Even With Exposure To Liquids Of Different Temperatures, Data Shows

Aquestive Therapeutics, Inc. - Common Stock

Aquestive Therapeutics Inc

Earnings

Press Releases

Aquestive Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

Aquestive Therapeutics to Participate in Two Upcoming Investor Conferences

Aquestive Therapeutics Announces Positive FDA Feedback and Reaffirms NDA Submission Guidance for Anaphylm™ (epinephrine) Sublingual Film

Aquestive Therapeutics Receives U.S. FDA Orphan Drug Exclusivity for Libervant® (diazepam) Buccal Film in Pediatric Patients with Seizure Clusters Ages Two to Five

Aquestive Therapeutics Provides Business Update and Outlines Key 2025 Objectives

Aquestive Therapeutics to Participate in Oppenheimer 35th Annual Healthcare Conference

Aquestive Therapeutics to Present New Findings on Anaphylm™ (Epinephrine Sublingual Film) at the 2025 AAAAI Annual Meeting

Aquestive Therapeutics to Report Fourth Quarter 2024 Financial Results and Recent Business Highlights on March 5 and Host Conference Call on March 6 at 8:00 a.m. ET

Aquestive Therapeutics to Participate in Two Upcoming Conferences in March

Aquestive Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Aardvark Therapeutics, Inc. - Common Stock

Aardvark Therapeutics

Aclaris Therapeutics, Inc. - Common Stock

Aclaris Therapeutics

Alumis

Amylyx Pharmaceuticals, Inc. - Common Stock

Amylyx Pharmaceuticals

Atea Pharmaceuticals, Inc. - common stock

Atea Pharmaceuticals

Cormedix

Contineum Therapeutics, Inc. - Common stock

Contineum Therapeutics

Esperion Therapeutics, Inc. - Common Stock

Esperion Therapeutics

Eton Pharmaceuticals, Inc. - Common Stock

Eton Pharmaceuticals

EyePoint Pharmaceuticals, Inc. - Common Stock

EyePoint Pharmaceuticals

Fulcrum Therapeutics, Inc. - Common Stock

Fulcrum Therapeutics

MBX Biosciences

Neumora Therapeutics, Inc. - Common Stock

Neumora Therapeutics

Phathom Pharmaceuticals, Inc. - Common Stock

Phathom Pharmaceuticals

Rapport Therapeutics, Inc. - Common Stock

Rapport Therapeutics

Regencell Bioscience Holdings Limited - Ordinary Shares

Regencell Bioscience

scPharmaceuticals

Septerna

SIGA Technologies

SNDL

Theravance Biopharma, Inc. - Ordinary Shares

Theravance Biopharma

Terns Pharmaceuticals, Inc. - Common Stock

Terns Pharma

Third Harmonic Bio

Zevra Therapeutics

Zhengye Biotechnology Holding Limited - Ordinary Shares

Comments

Aquestive Therapeutics

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga